MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis

Dan Yang1, Wei-Zhi Wang, Xue-Mei Zhang

  • 1Department of Neurology, Second Affiliated Hospital, Harbin Medical University, 246 Xuefu Road, Nangang District, Harbin, 150086, China.

Insights

This study identified distinct microRNA (miRNA) expression patterns in Chinese patients with multiple sclerosis (MS). These findings suggest specific miRNAs could serve as biomarkers for MS in this population.

Area of Science:

  • Immunology
  • Genetics
  • Neuroscience

Background:

  • Multiple sclerosis (MS) is a central nervous system autoimmune disease.
  • MicroRNAs (miRNAs) are crucial regulators of immune responses.
  • Previous miRNA research in MS predominantly focused on European cohorts.

Purpose of the Study:

  • To investigate miRNA expression profiles in Chinese multiple sclerosis patients.
  • To identify potential miRNA biomarkers for MS in a Chinese population.

Main Methods:

  • miRNA expression profiling of peripheral blood mononuclear leukocytes from MS patients and healthy controls.
  • Validation of differentially expressed miRNAs using real-time PCR in a larger cohort.
  • Principal component analysis to assess diagnostic potential of miRNA patterns.

Main Results:

  • Identified nine overexpressed and six underexpressed miRNAs in Chinese MS patients.
  • Six miRNAs showed significant differential expression upon validation.
  • miRNA expression patterns clearly distinguished MS patients from healthy controls.

Conclusions:

  • Abnormal miRNA expression patterns are indicated in Chinese MS patients' peripheral blood.
  • These differentially expressed miRNAs may hold potential as MS biomarkers.
  • Further research is needed to explore the role of these miRNAs in MS pathogenesis.